Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 9,000 shares at $43.41 ($391K) on 2021-04-14, disclosed to the SEC on 2021-04-16.
Open-market sale of $391k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.41 | 4,500 | $195K | 50.0% |
| 2 | $43.41 | 4,500 | $195K | 50.0% |
| Total | $43.41 avg | 9,000 | $391K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |